← Back to Search

Cognitive Remediation Therapy Program (BrainHQ) for Parkinson's Disease

N/A
Waitlist Available
Research Sponsored by New York Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up initially, before any intervention/start of study.
Awards & highlights

Study Summary

This study is evaluating whether a computerized cognitive remediation program can improve cognitive functioning in people with Parkinson's disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~initially, before any intervention/start of study.
This trial's timeline: 3 weeks for screening, Varies for treatment, and initially, before any intervention/start of study. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Montreal Cognitive Assessment (MOCA) Pre-Intervention Screening
Parkinson's Disease Questionnaire (PDQ-39) Post-Intervention
Parkinson's Disease Questionnaire (PDQ-39) Pre-Intervention
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Parkinson's Disease Patients receiving Cognitive Remediation TherapyExperimental Treatment1 Intervention
Parkinson's Disease Subjects will undergo 10 weeks of Brain HQ training, 2 times a week an hour at a time. Also patients pre- and post-intervention RBANS and PDQ-39 scores.
Group II: Parkinson's Disease Patients not receiving Cognitive Remediation TherapyActive Control1 Intervention
Parkinson's Disease Subjects will receive no intervention, but still undergo pre- and post-intervention RBANS and PDQ-39 scores.

Find a Location

Who is running the clinical trial?

New York Institute of TechnologyLead Sponsor
51 Previous Clinical Trials
2,046 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
The Efficacy of a Remote Cognitive Remediation Therapy (CRT) Program on Parkinson's Disease
2021. "The Efficacy of a Remote Cognitive Remediation Therapy (CRT) Program on Parkinson's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04955275.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top